Cargando…
Diet intake control is indispensable for the gluconeogenic response to sodium–glucose cotransporter 2 inhibition in male mice
AIMS/INTRODUCTION: Sodium–glucose cotransporter 2 inhibitor (SGLT2i) lowers blood glucose and causes a whole‐body energy deficit by boosting renal glucose excretion, thus affecting glucose and energy metabolism. This energy deficit not only decreases bodyweight, but also increases food intake. This...
Autores principales: | Hashiuchi, Emi, Watanabe, Hitoshi, Kimura, Kumi, Matsumoto, Michihiro, Inoue, Hiroshi, Inaba, Yuka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779272/ https://www.ncbi.nlm.nih.gov/pubmed/32515547 http://dx.doi.org/10.1111/jdi.13319 |
Ejemplares similares
-
Sirt2 facilitates hepatic glucose uptake by deacetylating glucokinase regulatory protein
por: Watanabe, Hitoshi, et al.
Publicado: (2018) -
Nicotinic alpha‐7 acetylcholine receptor deficiency exacerbates hepatic inflammation and fibrosis in a mouse model of non‐alcoholic steatohepatitis
por: Kimura, Kumi, et al.
Publicado: (2018) -
The transcription factor ATF3 switches cell death from apoptosis to necroptosis in hepatic steatosis in male mice
por: Inaba, Yuka, et al.
Publicado: (2023) -
Renal effects of a sodium‐glucose cotransporter 2 inhibitor, tofogliflozin, in relation to sodium intake and glycaemic status
por: Nunoi, Kiyohide, et al.
Publicado: (2019) -
Case of ketoacidosis by a sodium-glucose cotransporter 2 inhibitor in a diabetic patient with a low-carbohydrate diet
por: Hayami, Tomohide, et al.
Publicado: (2015)